In March, CEO Rupert spoke at the IBM Watson Health event on the role of Artificial Intelligence and Data Analytics in transforming healthcare.
Rupert discussed the importance of linking clinical, cost and operational datasets to ensure timely outcomes reporting, as well as how the unlocking of data could help achieve better, informed care decisions across pathways. He also emphasised the need to measure outcomes for healthy populations in addition to those who are already being treated for an illness, stating that this was an essential step forward in the proactive analysis required in order to effectively implement targeted prevention strategies.
The event, hosted at the King’s Fund and delivered in partnership with IBM Watson Health, discussed the latest opportunities that science and technology can bring to health and care, including their role in actioning the government’s focus on prevention outlined in the NHS Long Term Plan.
Nasrin Hafezparast
Co-Founder and CTO Dr Nasrin Hafezparast is co-founder and CTO at OBH. She is dual trained in both Computer Science and Medicine, both at University College London. As a fully qualified medical doctor, she has experience working as a doctor in A&E, General Practice and Hospital Medicine in London. Nasrin has an entrepreneurial background and skill set. She is a Teaching Fellow and co-leads the healthcare pathway in the MSc Technology Entrepreneurship at UCL, and is an Advisory Board member of Reform, the independent think-tank. She was selected by Management Today as one of ’35 women under 35′, and selected as one of ‘Twenty women in data & tech’ by The Female Lead and Women in Tech. She spoke at TEDxTehran on ‘Breaking through the disease barrier’. In addition, her interest in technology led her to co-found a website design and development agency in 2004 where she explored the online tech space and continues to manage a successful online B2B venture today. Nasrin brings an invaluable combination of technology and healthcare experience to OBH’s technical and process work on outcomes measurement. She has an extensive understanding and background in clinical and health datasets, and patient-reported data. Harvard Business School Value-Based Healthcare Delivery alumnus.
